ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,679.88
-0.03%
Dow Jones
42,801.72
0.52%
Gold vs US Dollar
2,911.205
0.02%
Brent Oil
70.235
1.29%
Bitcoin
86,233.67
-4.10%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Allurion Technologies Inc (ALUR)

  7. Allurion Technologies Inc (ALUR) News

Allurion Technologies (ALUR)

Allurion Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ALUR
DateTimeSourceHeadlineSymbolCompany
25/02/202521:05Business WireAllurion to Participate in Upcoming Investor ConferencesNYSE:ALURAllurion Technologies Inc
20/02/202521:05Business WireAllurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical PipelineNYSE:ALURAllurion Technologies Inc
19/02/202514:03Business WireAllurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical PipelineNYSE:ALURAllurion Technologies Inc
18/02/202513:30Business WireAllurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat ObesityNYSE:ALURAllurion Technologies Inc
13/02/202513:30Business WireAllurion Relaunches in FranceNYSE:ALURAllurion Technologies Inc
27/01/202514:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ALURAllurion Technologies Inc
24/01/202514:30Business WireAllurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-MarketNYSE:ALURAllurion Technologies Inc
23/01/202520:48Business WireAllurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion ProgramNYSE:ALURAllurion Technologies Inc
21/01/202513:30Business WireAllurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of ObesityNYSE:ALURAllurion Technologies Inc
14/01/202514:18Business WireAllurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024NYSE:ALURAllurion Technologies Inc
08/01/202513:00Business WireAllurion Announces Positive Topline Results From AUDACITY TrialNYSE:ALURAllurion Technologies Inc
24/12/202412:00Business WireAllurion Technologies, Inc. Announces Reverse Stock SplitNYSE:ALURAllurion Technologies Inc
02/12/202413:00Business WireAllurion Announces NYSE Acceptance of Plan to Regain Listing ComplianceNYSE:ALURAllurion Technologies Inc
25/11/202413:00Business WireAllurion Launches in the US with its First AI-Native Compounded GLP-1 ProgramNYSE:ALURAllurion Technologies Inc
13/11/202413:00Business WireAllurion Reports Third Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
04/11/202413:10Business WireAllurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual ConferenceNYSE:ALURAllurion Technologies Inc
30/10/202412:30Business WireAllurion to Report Third Quarter 2024 Financial Results on November 13, 2024NYSE:ALURAllurion Technologies Inc
23/10/202412:00Business WireAllurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion BalloonNYSE:ALURAllurion Technologies Inc
09/10/202412:00Business WireAllurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight LossNYSE:ALURAllurion Technologies Inc
02/10/202415:40AllPennyStocks.comCoverage Initiation And Bullish Price Target Sends Micro Cap FlyingNYSE:ALURAllurion Technologies Inc
01/10/202412:04Business WireAllurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight LossNYSE:ALURAllurion Technologies Inc
05/09/202421:30Business WireAllurion Receives Continued Listing Standards Notice from NYSENYSE:ALURAllurion Technologies Inc
05/09/202412:00Business WireAllurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from ObesityNYSE:ALURAllurion Technologies Inc
03/09/202412:00Business WireAllurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of DirectorsNYSE:ALURAllurion Technologies Inc
28/08/202412:28Business WireAllurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion ProgramNYSE:ALURAllurion Technologies Inc
20/08/202412:00Business WireAllurion Announces the Appointment of Adrian Wild as Senior Vice President, International CommercialNYSE:ALURAllurion Technologies Inc
15/08/202420:05Business WireAllurion Receives Continued Listing Standards Notice from NYSENYSE:ALURAllurion Technologies Inc
13/08/202412:00Business WireAllurion Reports Second Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
06/08/202414:20Business WireAllurion suspend les ventes et retire l'approvisionnement du Ballon Allurion en France jusqu’à la mise en œuvre d'un plan de réduction des risquesNYSE:ALURAllurion Technologies Inc
16/07/202420:05Business WireAllurion to Report Second Quarter 2024 Financial Results on August 13, 2024NYSE:ALURAllurion Technologies Inc
 Showing the most relevant articles for your search:NYSE:ALUR

Your Recent History

LSE
SI87
Rep.albnia 31 A
TSX
AND
Andlauer Heathcare
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads